Redpoint Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $296K | Sell |
709
-101
| -12% | -$42.2K | 0.04% | 460 |
|
|
2022
Q2 | $401K | Hold |
810
| – | – | 0.05% | 422 |
|
|
2022
Q1 | $456K | Sell |
810
-187
| -19% | -$105K | 0.05% | 440 |
|
|
2021
Q4 | $753K | Buy |
997
+184
| +23% | +$139K | 0.06% | 356 |
|
|
2021
Q3 | $606K | Hold |
813
| – | – | 0.05% | 401 |
|
|
2021
Q2 | $524K | Hold |
813
| – | – | 0.04% | 440 |
|
|
2021
Q1 | $464K | Buy |
813
+324
| +66% | +$185K | 0.04% | 451 |
|
|
2020
Q4 | $285K | Buy |
+489
| New | +$285K | 0.03% | 489 |
|